PS
UTHR icon

Planning Strategies’s United Therapeutics UTHR Stock Holding History

Planning Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542 Buy
+1
New +$563 ﹤0.01% 846

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Planning Strategies's UTHR Position: Q2 2026 in Review

Planning Strategies opened a new position in United Therapeutics (UTHR) in Q2 2026: 1 share worth $542. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Planning Strategies held 1 share of United Therapeutics worth $542 as of Q2 2026.
  • United Therapeutics was a new Planning Strategies position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Planning Strategies's portfolio in Q2 2026, its #846 holding.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.